CETJOINT K2 7 Capsule 15's

CETJOINT K2 7 CAPSULE is used to manage osteoporosis, which is a condition that causes thinning and weakening of bones because of excessive absorption of calcium from the bones. It is characterized by symptoms such as bleeding gums, weak grip strength, brittle fingernails, loss of height, frequent fractures, and neck and back pain.

If you or anyone else accidentally takes too much CETJOINT K2 7 CAPSULE, consult your doctor immediately or visit the nearby hospital. Symptoms of an overdose are increased blood calcium levels (increased thirst, frequent urination, stomach pain, nausea, bone pain, muscle weakness, confusion, and fatigue), excess calcium in the urine (blood in urine, pain while urinating), hyperphosphatemia (muscle cramps and numbness), nausea, vomiting, constipation, abdominal pain, muscle weakness, tiredness, mental disturbances, lack of appetite, bone pain, kidney problems, an irregular heartbeat, irritability, a continuing headache, lightheadedness, and muscle spasms, twitches, and a tingling sensation are also symptoms.

The common side effects associated with the use of CETJOINT K2 7 CAPSULE are diarrhea, constipation, an upset stomach, and abdominal pain. Contact your doctor or a nearby hospital if any of the conditions worsen.

CETJOINT K2 7 CAPSULE is not recommended for use if you are allergic to calcitriol or calcium. It is also not recommended for use if you have kidney stones, hypercalcaemia (high blood calcium levels), or evidence of vitamin D toxicity. It is not recommended to be used by breastfeeding women. Consult your doctor before taking it.

CETJOINT K2 7 CAPSULE should be used with caution in children (below 6 years) and elderly patients (aged 65 years or older). Your doctor will determine the correct dose and duration for you depending upon your age, body weight, and disease condition.

CETJOINT K2 7 CAPSULE helps in managing bone weakening, where calcitriol plays a very important role in aiding the absorption of calcium by acting on certain gut cells to increase the production of calcium transport proteins, whereas calcium carbonate acts by directly increasing the calcium stores in the body. Vitamin K activates the calcium-binding actions of two proteins (the matrix GLA protein and osteocalcin), which helps in enhancing calcium absorption in the body, thereby increasing bone mass and strength.

Take CETJOINT K2 7 CAPSULE as advised by your physician. Swallow the medicine with a glass of water and food. Do not crush or chew the medicine. Your doctor will determine the correct dose and duration for you depending upon your age, body weight, and disease condition.

If you forgot to take your CETJOINT K2 7 CAPSULE dose, take it as early as possible. Do not double up the dose to make up for the forgotten one. Consult your doctor before taking it.

CETJOINT K2 7 CAPSULE is not recommended for use if you have kidney stones. It should be used with caution in patients with nephrotic diseases (a kidney disease causing excess protein in your urine), chronic renal failure, or a high tendency to get kidney stones. It should also be used with caution in patients undergoing dialysis. Consult your doctor for advice before taking it.

CETJOINT K2 7 CAPSULE should be used with caution in pregnant women only if clearly necessary. It is not recommended to be used by breastfeeding women. Consult your doctor before taking it.